MAHDI DOUMET: Open Payments
NPI 1801880471 · PERRYSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 32 payments from 15 companies in 2025. Trend: 2023 $872 · 2024 $549 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $121 |
| Exact Sciences Corporation | 4 | $84 |
| Abbott Laboratories | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Amgen Inc. | 2 | $51 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
Products named: CAPLYTA, Cologuard Collection Kit, FREESTYLE LIBRE 3, FARXIGA, MOUNJARO, Ozempic, REPATHA, REXULTI.
Industry payments across OH — which companies pay providers there.
